You are not alone
Some people don't get them at all, but you have to do that at scale at a population level
It does this by: Stimulating your pancreas to release insulin (which lowers blood sugar) Slowing down how fast your stomach empties (so you feel full longer) Reducing the release of another hormone called glucagon (which raises blood sugar) Acting on the brain to decrease appetite In people with type 2 diabetes or metabolic challenges, the body either doesnt make enough GLP-1 or doesnt respond to it properly
In September 1986 Mojsov and Habener's team published a joint article which drew very heavily on Mojsovs experiments and analysis
GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro) work by slowing gastric emptying and activating receptors in the brainstem, which can trigger nausea and vomiting
Metabolism: They slow gastric emptying (making you feel full longer) and can improve heart and liver health markers
